|
Study Characteristics |
||||||||||
| Year |
Type |
Det |
Age |
M/F |
Prob |
INC |
NAP |
Outc |
NCA |
|
|
|
||||||||||
| White8 |
2005 |
PC |
16 |
51 |
1.03 |
All** |
69 |
0 |
CLIN |
- |
| Gallagher9 |
2006 |
PC |
64 |
49 |
0.53 |
Low |
96 |
0.07 |
CLIN |
5 |
| Hoffmann10 |
2006 |
PC |
16/64 |
57 |
0.53 |
All** |
40 |
0 |
CLIN |
- |
| Hoffmann11 |
2006 |
PC |
64 |
54 |
0.58 |
All** |
106 |
0.03 |
CLIN |
8 |
| Olivetti12 |
2006 |
PC |
16 |
59 |
0.61 |
U |
31 |
0 |
CA |
31 |
| Sato13 |
2006 |
PC |
4/16 |
60 |
0.85 |
U |
34 |
0.09 |
CLIN |
- |
| Goldstein14 |
2007 |
RCT |
64 |
48 |
0.43 |
Low |
99 |
0.11 |
CLIN |
12 |
| Meijboom15 |
2007 |
PC |
64 |
59 |
0,76 |
Low |
33 |
0 |
CA |
33* |
| Rubinshtein16 |
2007 |
PC |
64 |
56 |
1.76 |
Int |
58 |
0 |
CLIN |
17 |
|
Type: Study type. RCT: Randomized controlled trial. PC: Prospective cohort. Det: Number of detectors. M/F: Male/Female ratio. Prob: Pre-test probability. INC: Number of included patients. NAP: Non assessable proportion of patients = Ratio of non-diagnostic versus included patients. Outc: reference standard used. NCA: Number of patients that underwent Conventional Angiography. Clin: Clinical. U: Unknown. *:only a fraction of the patients were included: the patients that clearly had negative biomarkers and were categorized as "low risk" in this study. **: included patients with pre-test probability ranging from low to high | ||||||||||
Vanhoenacker et al. BMC Cardiovascular Disorders 2007 7:39 doi:10.1186/1471-2261-7-39 |
||||||||||